Tag: Cancer: Rectal
Locally Recurrent Rectal Cancer QoL Is Valid Patient-Reported Outcome Measure
LRRC-QoL consisted of nine multi-item scales and three single items; has convergent validity with other measures
ASCO: FOLFOX Noninferior to Chemoradiotherapy for Overall Survival in Rectal Cancer
Findings seen in patients with locally advanced rectal cancer who were eligible for sphincter-sparing surgery
ASCO: Microbiome Varies for Early-Onset, Late-Onset Colorectal Cancer
Cladosporium sp. was more commonly found in early-onset CRC, while Pseudomonas luteola, Ralstonia sp., Moraxella osloensis occurred more often in late-onset CRC
Red-Flag Signs May Indicate Early-Onset Colorectal Cancer
Abdominal pain, rectal bleeding, diarrhea, and iron deficiency anemia seen up to two years before diagnosis
Overweight, Obesity in Early, Middle Adulthood Increases Risk for GI Cancers
Risk not reduced with aspirin use three or more times per week for colorectal and noncolorectal cancers
FTD-TPI Plus Bevacizumab Increases Survival in Refractory Advanced CRC
Significantly longer overall survival and progression-free survival seen for combination versus TFD-TPI alone
Risk for Early-Onset CRC Increased in Women Born Via C-Section
Authors say finding may be explained by early-life gut dysbiosis
Prediagnostic Weight Loss Underestimates Risk for Colorectal Cancer
Association for high BMI and colorectal cancer risk most pronounced using BMI at least eight years before diagnosis
Partners of CRC Survivors Experience Long-Term Financial Toxicity
Furthermore, this financial toxicity is associated with worse health-related quality of life
Higher Risk for CRC Seen in Adults Exposed to Bendectin In Utero
Risk of colorectal cancer higher in offspring exposed in utero during 1960s versus unexposed offspring
